On the predictability of progression-free survival in ovarian cancer from NanoString gene expression data
Lucy B. Van Kleunen, Grace I. Bowman, Sarah Elizabeth Stockman, Hope A. Townsend, Logan Barrios, Kimberly Rae Jordan, Rebecca J. Wolsky, Kian Behbakht, Matthew J. Sikora, Jennifer K. Richer, Junxiao Hu, Benjamin Guy Bitler, Aaron J. Clauset
This study investigates the predictability of progression-free survival in ovarian cancer using NanoString gene expression data from pre- and post-chemotherapy samples, finding low predictability and suggesting the need for larger datasets.
bioRxiv · Apr 24, 2026 · PreprintCancer Biology